I agree with James. It appears you have a one-way layout with four groups. The simplest approach, then, would be to just parameterize the design matrix using these four groups. For example, if you have two replicates in each group, you can do:
grouping <- c("WT", "WT", "R", "R", "A", "A", "RA", "RA")
design <- model.matrix(~0+grouping)
This approach will be the easiest to interpret, as you can formulate the contrasts to compare between your groups.
If you want an genetic interaction model (e.g., to consider epistasis), then you might do something like this. I'll reuse the example above, and assume that R and A are mutations in separate genes. We can then do:
is.a <- c(0,0,0,0,1,1,1,1)
is.r <- c(0,0,1,1,0,0,1,1)
design <- model.matrix(~factor(is.a)*factor(is.r))
If you drop the fourth coefficient, you're testing the interaction between genotypes R and A, i.e., your null hypothesis is that the combined effect of genotype RA is equal to the sum of the individual effects for genotypes R and A. Rejection may indicate epistasis (where the combined effect is less than the predicted additive effect) or synergy (if the combined effect is greater).
---
Edit: Mind you, the results from the second approach can be quite difficult to interpret. You'll need to look at the signs of the second and third coefficients to figure out what's going on. For example, if both the A and R mutations result in a 2-fold increase over WT, then a positive value for the RA interaction term might represent synergy. On the other hand, if both single mutations result in a 2-fold decrease against WT, then a positive value for the RA interaction term might represent epistasis (as additional decreases are not observed). One could also imagine a bunch of strange scenarios; for example, if A results in a 2-fold increase and R results in a 2-fold decrease, then a positive RA interaction term might represent some dominance effect of A over R.
What's the interaction in this case? It seems to me you just have four groups, and want to compare, which means there isn't really an interaction (except possibly in a genetic context). Statistically, for there to be an interaction, you would need say two genotypes and two treatments, not four different genotypes.